Table 1. Summary statistics of demographics and clinical characteristics by sex (N=3174).
| Variable | Males N=1747 | Females N=1427 | P-value |
|---|---|---|---|
| Age mean ± SD | 56.8±11.1 | 56.5±11.4 | 0.474 |
|
| |||
| ABI mean ± SD | 1.13 ±0.15 | 1.08 ±0.13 | <0.001 |
| Race | <0.001 | ||
| White | 50.9% | 43.9% | ----- |
| Black | 35.7% | 45.1% | ----- |
| Other | 13.4% | 11.1% | ----- |
| Diabetes | 44.5% | 43.4% | 0.535 |
| eGFR | 47.3±16.6 | 46.0± 17.8 | 0.040 |
| BMI | 31.1±6.3 | 32.9±9.1 | <0.001 |
| CHF | 8.9% | 7.2% | 0.076 |
| Hypertension | 86.1% | 82.2% | 0.003 |
| CAD | 20.6% | 13.0% | <0.001 |
| Smoking | <0.001 | ||
| Never | 41.9% | 58.1% | ----- |
| Former | 45.7% | 31.0% | ----- |
| Current | 12.4% | 10.9% | ----- |
| Hypercholesterolemia | 85.2% | 73.5% | <0.001 |
| COPD | 2.2% | 3.0% | 0.147 |
| ACE inhibitor | 53.7% | 40.6% | <0.001 |
| ARB | 26.1% | 24.4% | 0.277 |
| Beta blocker | 47.7% | 44.4% | 0.066 |
| Statin | 53.1% | 49.2% | 0.027 |
| Aspirin | 41.6% | 36.6% | 0.004 |
*
eGFR-estimated glomerular filtration rate, BMI-body mass index, CHF-congestive heart failure, CAD-coronary artery disease, COPD-chronic obstructive pulmonary disease, ACE-angiotensin-converting-enzyme, ARB-Angiotensin receptor blockers
Ɨ
p-value represents the comparison of continuous and categorical variables by sex